Jay T. Flatley

Non-Executive Chairman
Healthcare
DEZZEL MEDIA BV
American Samoa

Physician Clinical Sciences
Biography

 resenting a compound annual growth rate of 64 percent.  He oversaw the company’s expansion from microarrays into next-generation sequencing with the acquisition of Solexa in 2006, and from research into clinical and applied markets.  Under his leadership, Illumina was named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fa

Research Intrest

 resenting a compound annual growth rate of 64 percent.  He oversaw the company’s expansion from microarrays into next-generation sequencing with the acquisition of Solexa in 2006, and from research into clinical and applied markets.  Under his leadership, Illumina was named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fa

Global Scientific Words in Clinical Sciences